• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.肺结核后肺疾病的评估、管理和康复临床标准。
Int J Tuberc Lung Dis. 2021 Oct 1;25(10):797-813. doi: 10.5588/ijtld.21.0425.
2
Clinical standards for the diagnosis, treatment and prevention of TB infection.肺结核感染的诊断、治疗和预防临床标准。
Int J Tuberc Lung Dis. 2022 Mar 1;26(3):190-205. doi: 10.5588/ijtld.21.0753.
3
Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.临床诊断、治疗和预防新冠后肺部疾病标准。
Int J Tuberc Lung Dis. 2023 Oct 1;27(10):729-741. doi: 10.5588/ijtld.23.0248.
4
Clinical standards for drug-susceptible pulmonary TB.耐药结核病临床诊疗指南
Int J Tuberc Lung Dis. 2022 Jul 1;26(7):592-604. doi: 10.5588/ijtld.22.0228.
5
Clinical standards for the dosing and management of TB drugs.结核病药物剂量和管理的临床标准。
Int J Tuberc Lung Dis. 2022 Jun 1;26(6):483-499. doi: 10.5588/ijtld.22.0188.
6
Implementation of spirometry screening for post-tuberculosis lung disease (PTLD) among adolescents and adults enrolled within the National Tuberculosis Control Program of Carmelo Hospital in Chókwè District, Mozambique: A hybrid type III effectiveness-implementation study protocol.在莫桑比克乔奎医院国家结核病控制项目中,对青少年和成年结核病后肺部疾病(PTLD)进行肺功能筛查的实施:一项混合 III 型有效性实施研究方案。
BMC Pulm Med. 2024 Oct 10;24(1):502. doi: 10.1186/s12890-024-03329-7.
7
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
8
Standards for clinical trials for treating TB.治疗结核病的临床试验标准。
Int J Tuberc Lung Dis. 2023 Dec 1;27(12):885-898. doi: 10.5588/ijtld.23.0341.
9
Post-tuberculosis lung disease in children and adolescents: A scoping review of definitions, measuring tools, and research gaps.儿童和青少年肺结核后肺部疾病:关于定义、测量工具及研究空白的范围综述
Paediatr Respir Rev. 2025 Mar;53:55-63. doi: 10.1016/j.prrv.2024.07.001. Epub 2024 Jul 18.
10
Culturally adapted pulmonary rehabilitation for adults living with post-tuberculosis lung disease in Kyrgyzstan: protocol for a randomised controlled trial with blinded outcome measures.文化适应性肺康复治疗吉尔吉斯斯坦肺结核病后成人:一项采用盲法结局测量的随机对照试验方案。
BMJ Open. 2022 Feb 21;12(2):e048664. doi: 10.1136/bmjopen-2021-048664.

引用本文的文献

1
Community-based pulmonary rehabilitation for post-TB lung disease - a programmatic intervention.基于社区的结核病后肺部疾病肺康复——一项计划性干预措施。
IJTLD Open. 2025 Aug 13;2(8):459-463. doi: 10.5588/ijtldopen.25.0201. eCollection 2025 Aug.
2
Assessment of comorbidities, risk factors, and post tuberculosis lung disease in National Tuberculosis Guidelines: A scoping review.《国家结核病指南中合并症、危险因素及结核病后肺部疾病的评估:一项范围综述》
PLOS Glob Public Health. 2025 Jul 23;5(7):e0004935. doi: 10.1371/journal.pgph.0004935. eCollection 2025.
3
Post-TB lung function, quality of life, and radiographic findings in children.儿童肺结核后的肺功能、生活质量及影像学表现
IJTLD Open. 2025 Jul 9;2(7):427-433. doi: 10.5588/ijtldopen.24.0675. eCollection 2025 Jul.
4
Effect of home-based pulmonary rehabilitation on ventilation dynamics and small airway dysfunction in people with post-tuberculosis lung disease.家庭肺康复对肺结核后肺部疾病患者通气动力学和小气道功能障碍的影响。
J Clin Tuberc Other Mycobact Dis. 2025 Jun 14;40:100542. doi: 10.1016/j.jctube.2025.100542. eCollection 2025 Aug.
5
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis.在艾滋病毒高流行地区,进展性肺损伤和结核病后遗症对及时治疗结核病的健康益处的影响:一项数学建模分析
Lancet Glob Health. 2025 Jul;13(7):e1240-e1249. doi: 10.1016/S2214-109X(25)00114-7.
6
Clinical best practices for caring for people with expanded resistance to newer TB drugs.针对对新型结核病药物具有广泛耐药性患者的临床最佳护理实践。
IJTLD Open. 2025 Jun 13;2(6):315-323. doi: 10.5588/ijtldopen.25.0240. eCollection 2025 Jun.
7
Pulmonary rehabilitation for post-TB lung disease led by TB survivors.由结核病幸存者主导的肺结核后肺部疾病的肺康复治疗。
Public Health Action. 2025 Jun 4;15(2):82-87. doi: 10.5588/pha.25.0001. eCollection 2025 Jun.
8
Post-pulmonary tuberculosis lung function: a systematic review and meta-analysis.肺结核后肺功能:一项系统评价与荟萃分析
Lancet Glob Health. 2025 Jun;13(6):e1020-e1029. doi: 10.1016/S2214-109X(25)00105-6.
9
Correlations between exercise oxygen consumption, lung function, image findings, and quality of life in adults with post-tuberculosis lung disease.肺结核后肺部疾病成人患者运动耗氧量、肺功能、影像表现及生活质量之间的相关性
Chron Respir Dis. 2025 Jan-Dec;22:14799731251345492. doi: 10.1177/14799731251345492. Epub 2025 May 22.
10
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe.肯尼亚、乌干达、赞比亚和津巴布韦治疗开始时的结核病残疾和多种疾病并存情况。
IJTLD Open. 2025 May 12;2(5):291-298. doi: 10.5588/ijtldopen.25.0171. eCollection 2025 May.

本文引用的文献

1
The burden and determinants of post-TB lung disease.结核后肺部疾病的负担和决定因素。
Int J Tuberc Lung Dis. 2021 Oct 1;25(10):846-853. doi: 10.5588/ijtld.21.0278.
2
Assessment of TB treatment on patient well-being.结核病治疗对患者健康状况的评估。
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):315-317. doi: 10.5588/ijtld.21.0816.
3
Doxycycline host-directed therapy in human pulmonary tuberculosis.多西环素宿主导向治疗人类肺结核。
J Clin Invest. 2021 Aug 2;131(15). doi: 10.1172/JCI141895.
4
Pulmonary Rehabilitation in Patients Recovering from COVID-19.新型冠状病毒肺炎患者的肺康复治疗。
Respiration. 2021;100(5):416-422. doi: 10.1159/000514387. Epub 2021 Mar 30.
5
Health-related quality of life associates with clinical parameters in patients with NTM pulmonary disease.在非结核分枝杆菌肺病患者中,与健康相关的生活质量与临床参数相关。
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):299-304. doi: 10.5588/ijtld.20.0790.
6
Impact of lung function on treatment outcome in patients with TB.肺功能对结核病患者治疗结局的影响。
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):277-284. doi: 10.5588/ijtld.20.0949.
7
Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function.尽管结核病已治愈,但持续存在的慢性呼吸道症状与肺功能相关性较差。
Int J Tuberc Lung Dis. 2021 Apr 1;25(4):262-270. doi: 10.5588/ijtld.20.0906.
8
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.辅助宿主导向疗法治疗肺结核:一项前瞻性、开放标签、2 期、随机对照试验。
Lancet Respir Med. 2021 Aug;9(8):897-908. doi: 10.1016/S2213-2600(20)30448-3. Epub 2021 Mar 16.
9
Clinical care for patients with post-TB lung disease.肺结核后肺部疾病患者的临床护理。
Int J Tuberc Lung Dis. 2021 Mar 1;25(3):252-253. doi: 10.5588/ijtld.20.0824.
10
Different disease, same challenges: Social determinants of tuberculosis and COVID-19.不同的疾病,同样的挑战:结核病和 COVID-19 的社会决定因素。
Pulmonology. 2021 Jul-Aug;27(4):338-344. doi: 10.1016/j.pulmoe.2021.02.002. Epub 2021 Feb 19.

肺结核后肺疾病的评估、管理和康复临床标准。

Clinical standards for the assessment, management and rehabilitation of post-TB lung disease.

机构信息

Respiratory Diseases Clinical Epidemiology Unit, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy.

Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa, DSI-NRF South African Centre of Excellence in Epidemiological Modelling and Analysis (SACEMA), Stellenbosch University, Stellenbosch, South Africa.

出版信息

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):797-813. doi: 10.5588/ijtld.21.0425.

DOI:10.5588/ijtld.21.0425
PMID:34615577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8504493/
Abstract

Increasing evidence suggests that post-TB lung disease (PTLD) causes significant morbidity and mortality. The aim of these clinical standards is to provide guidance on the assessment and management of PTLD and the implementation of pulmonary rehabilitation (PR). A panel of global experts in the field of TB care and PR was identified; 62 participated in a Delphi process. A 5-point Likert scale was used to score the initial ideas for standards and after several rounds of revision the document was approved (with 100% agreement). Five clinical standards were defined: Standard 1, to assess patients at the end of TB treatment for PTLD (with adaptation for children and specific settings/situations); Standard 2, to identify patients with PTLD for PR; Standard 3, tailoring the PR programme to patient needs and the local setting; Standard 4, to evaluate the effectiveness of PR; and Standard 5, to conduct education and counselling. Standard 6 addresses public health aspects of PTLD and outcomes due to PR. This is the first consensus-based set of Clinical Standards for PTLD. Our aim is to improve patient care and quality of life by guiding clinicians, programme managers and public health officers in planning and implementing adequate measures to assess and manage PTLD.

摘要

越来越多的证据表明,肺结核后肺部疾病(PTLD)会导致严重的发病率和死亡率。这些临床标准旨在为 PTLD 的评估和管理以及肺康复(PR)的实施提供指导。确定了一组在结核病护理和 PR 领域的全球专家小组;有 62 人参加了德尔菲流程。使用 5 点李克特量表对标准的初始想法进行评分,经过几轮修订后,该文件获得通过(达成 100%一致)。确定了五个临床标准:标准 1,在结核病治疗结束时评估患者是否存在 PTLD(针对儿童和特定环境/情况进行调整);标准 2,识别适合 PR 的 PTLD 患者;标准 3,根据患者需求和当地情况定制 PR 计划;标准 4,评估 PR 的效果;标准 5,开展教育和咨询。标准 6 涉及 PTLD 的公共卫生方面和 PR 导致的结果。这是第一套基于共识的 PTLD 临床标准。我们的目标是通过指导临床医生、项目管理人员和公共卫生官员规划和实施充分的措施来评估和管理 PTLD,从而改善患者的护理和生活质量。